SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-160512
Filing Date
2016-12-05
Accepted
2016-12-05 08:30:34
Documents
9
Period of Report
2016-12-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-22588_28k.htm 8-K 26742
2 EX-99.1 a16-22588_2ex99d1.htm EX-99.1 25647
3 EX-99.2 a16-22588_2ex99d2.htm EX-99.2 9112
4 EX-99.3 a16-22588_2ex99d3.htm EX-99.3 69612
5 GRAPHIC g225882mqi001.jpg GRAPHIC 7774
6 GRAPHIC g225882mqi002.gif GRAPHIC 655
7 GRAPHIC g225882mqi003.jpg GRAPHIC 7490
8 GRAPHIC g225882moi001.gif GRAPHIC 165929
9 GRAPHIC g225882mmi001.jpg GRAPHIC 3377
  Complete submission text file 0001104659-16-160512.txt   388196
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 162032731
SIC: 2834 Pharmaceutical Preparations